Patent details

EP1605932 Title: INTRANASAL FORMULATION OF ROTIGOTINE

Basic Information

Publication number:
EP1605932
PCT Application Number:
PCT/EP/2004/014626
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048042212
PCT Publication Number:
WO/2005/063236
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTRANASAL FORMULATION OF ROTIGOTINE
French Title of Invention:
FORMULATION INTRANASALE DE ROTIGOTINE
German Title of Invention:
INTRANASALE FORMULIERUNG MIT ROTIGOTIN
SPC Number:

Dates

Filing date:
22/12/2004
Grant date:
24/05/2006
EP Publication Date:
24/05/2006
PCT Publication Date:
14/07/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2005
EP B1 Publication Date:
24/05/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/12/2011
Expiration date:
22/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/10/2010
 
 

Name:
UCB PHARMA GMBH
Address:
ALFRED NOBEL STRASSE 10, 40789, MONHEIM, Germany (DE)

History of Owners

From:
22/12/2004
To:
26/10/2010

Name:
SCHWARZ PHARMA AG
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld., Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/10/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
KRÄMER Robert
Address:
Germany (DE)

Priority

Priority Number:
03029680
Priority Date:
23/12/2003
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/381;
Filing date Document type Number of pages